The Latest Breaking News from Alzheimer Disease

Researchers say clinical trials are needed to determine the biological trajectory of Alzheimer’s disease

Analysis of blood samples finds women with the disease have 20% lower levels, a pattern not seen in men

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion on Friday recommending Eli Lilly and Co.’s (NYSE:LLY) donanemab for early symptomatic Alzheimer’s disease in adults with confirmed amyloid pathology who are apolipoprotein E ε4 (ApoE4) heterozygotes or non-carriers.

Researchers say the findings provide new insights into possible early indicators of Alzheimer’s disease

One in three older Americans dies with Alzheimer's or another dementia

For years, scientists have assumed high levels of p-tau217 always spell trouble. The new research suggests they’ve been wrong

A protein long blamed for the brain damage seen in Alzheimer’s disease has now been found in astonishingly high levels in healthy newborn babies, challenging decades of medical dogma.

Scientists have discovered an Alzheimer's biomarker in newborn brains for the first time. This breakthrough could lead to earlier detection and prevention of Alzheimer's disease.

South Korean researchers say they had found an 8 percent lower risk